Skip to main content

Exposure Treatment of Agoraphobia with Panic Attacks: Are Drugs Essential?

  • Conference paper
Panic and Phobias 2

Abstract

There is a body of opinion that holds that panic disorder and agoraphobia are different to the other anxiety disorders. This opinion is based on three sets of observations:

  1. a)

    panic disorder and agoraphobia seem to be influenced by specific genetic factors;

  2. b)

    the attacks of panic can be precipitated by the administration of lactate and other substances; and

  3. c)

    treatment with antidepressants is “uniquely effective” (Sheehan 1982).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andrews G (1984) On the promotion of non-drug treatments. Br Med J 289: 994–995

    Article  Google Scholar 

  • Andrews G, Moran C (1986) The control of hyperventilation. Videotape. Audio Visual Unit, University of New South Wale, Sydney

    Google Scholar 

  • Andrews G, Guitar B, Howie P (1980) Meta-analysis of the effects of stuttering treatment. J Speech Hear Disord 45: 289–307

    Google Scholar 

  • Andrews G, MacMahon SW, Austin A et al (1982) Hypertension: a comparison of drug and non-drug treatments. Br Med J 284: 1523–1526

    Article  Google Scholar 

  • Andrews G, Allen R, Henderson AS (1987) The genetics of four anxiety disorders: a twin study. J Affective Disord (in press)

    Google Scholar 

  • Andrews G, Hadzi-Pavlovic D, Christensen H et al. (1988) The treatment of anxiety and somatoform disorders: views of practising psychiatrists. Am J Psychiatry (in press)

    Google Scholar 

  • Christensen H, Hadzi-Pavlovic D, Andrews G (1987) Behavior therapy and tricyclic medication in the treatment of obsessive compulsive disorder: a quantitative review. J Consult Clin Psycho] 55: 000–000

    Google Scholar 

  • Craig A, Franklin J, Andrews G (1984) A scale to measure locus of control of behaviour. Br J Med Psychol 57: 173–180

    Article  PubMed  Google Scholar 

  • Craig A, Andrews G (1985) The prediction and prevention of relapse in stuttering: the value of self-control techniques and locus of control measures. Behav Modif 9: 427–442

    Article  PubMed  Google Scholar 

  • Derogatis LR, Lipman RS, Rickels K et al (1974) The Hopkins Symptoms Check List (HSCL): a self-report symptom inventory. Behav Sci 19: 1–15

    Article  PubMed  Google Scholar 

  • Emmelkamp PM, Emmelkamp-Benner A (1975) Effects of historically portrayed modeling and group treatment on self observation: a comparison with agoraphobics. Behav Res Ther 13: 135–139

    Article  PubMed  Google Scholar 

  • Emmelkamp PM, Mersch PP (1982) Cognition and exposure in vivo in the treatment of agoraphobia: short-term and delayed effects. Cogn Ther Res 6: 77–89

    Article  Google Scholar 

  • Emmelkamp PM, Wessels H (1975) Flooding in imagination versus flooding in vivo: a comparison with agoraphobies. Behav Res Ther 13: 7–15

    Article  PubMed  Google Scholar 

  • Emmelkamp PM, Kuipers AC, Eggeraat JB (1978) Cognitive modification versus prolonged exposure in vivo: a comparison with agoraphobies as subjects. Behav Res Ther 16: 33–41

    Article  PubMed  Google Scholar 

  • Emmelkamp PM, van der Hout A, Devries K (1983) Assertive training for agoraphobia. Behav Res Ther 21: 63–68

    Article  PubMed  Google Scholar 

  • Ellis A (1962) Reason and emotion in psychotherapy. Lyle-Stuart, New York

    Google Scholar 

  • Eysenck HJ, Eysenck SBG (1964) Manual of the Eysenck personality inventory. University of London Press, London

    Google Scholar 

  • Hafner J, Marks I (1976) Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. Psycho] Med 6: 71–88

    Article  Google Scholar 

  • Henderson AS (1981) Neurosis and the social environment. Academic, Sydney

    Google Scholar 

  • Holt PE, Andrews G (in press) Provocation of panic: a comparison on three elements of the panic reaction in four anxiety disorders. J Abnorm Psychol

    Google Scholar 

  • Jacobsen E (1938) Progressive relaxation. University of Chicago Press, Chicago

    Google Scholar 

  • Jakubowski P, Lange AJ (1976) Responsible assertive behavior: assertive option. Research Press, Champaign

    Google Scholar 

  • Kelly D, Guirguis W, Frommer E et al (1970) Treatment of phobic states with anti-depressants: a retrospective study of 246 patients. Br J Psychiatry 116: 387–398

    Article  PubMed  Google Scholar 

  • Lipsedge MJ, Hajioff J, Huggins P et al (1973) The management of severe agoraphobia: a comparison of iproniazid and systematic desensitisation. Psychopharmacologia 32: 67–80

    Article  PubMed  Google Scholar 

  • Marks I (1975) Behavioral treatments of phobic and obsessive-compulsive disorders: a critical apparaisal. In: Herson M, Eisler R, Miller P (eds) Progress in behavior modification, vol 1. Academic, New York

    Google Scholar 

  • Marks IM, Gray S, Cohen D et al (1983) Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatry 40: 153–162

    PubMed  Google Scholar 

  • Mavissakalian M, Michelson L (1982) Agoraphobia: behavioral and pharmacological treatments, preliminary outcome, and process findings. Psychopharmacol Bull 18: 91–103

    PubMed  Google Scholar 

  • Mavissakalian M, Penel J (1985) Imipramine in the treatment of agoraphobia: dose-response relationships. Am J Psychiatry 142: 1032–1036

    PubMed  Google Scholar 

  • Mavissakalian M, Michelson L, Pealy RS (1983) Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice. Br J Psychiatry 143: 348–355

    Article  PubMed  Google Scholar 

  • Mavissakalian M, Michelson L, Greenwald D et al (1983) Cognitive-behavioural treatment of agoraphobia: paradoxical intention versus self-statement training. Behav Res Ther 21: 75–86

    Article  PubMed  Google Scholar 

  • Moran C, Andrews G (1985) The familial occurrence of agoraphobia. Br J Psychiatry 146: 262–267

    Article  PubMed  Google Scholar 

  • Noyes R, Anderson D, Clancy J et al (1984) Diazepam and propranolol in panic disorder and agoraphobia. Arch Gen Psychiatry 41: 287–292

    PubMed  Google Scholar 

  • Ost LG, Jerramalm A, Jansson L (1984) Individual response patterns and the effects of different behavioural methods in the treatment of agoraphobia. Behav Res Ther 22: 697–707

    Article  PubMed  Google Scholar 

  • Robins LN, Helzer JG, Croughan J et al (1981) National Institutes of Mental Health Diagnostic Interview Schedule. Its history, characteristics and validity. Arch Gen Psychiatry 38: 381–389

    Google Scholar 

  • Robins LN, Helzer JE, Weissman MM et al (1984) Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 41: 949–958

    PubMed  Google Scholar 

  • Sheehan DV (1982) Panic attacks and phobias. N Engl J Med 307: 156–158

    Article  PubMed  Google Scholar 

  • Sheehan DV, Ballinger J, Jacobsen G (1980) Treatment of endogenous anxiety with phobic, hysterical and hypochondrical symptoms. Arch Gen Psychiatry 37: 51–59

    PubMed  Google Scholar 

  • Sheehan DV, Coleman JH, Greenblatt DJ et al (1984) Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. J Clin Psychopharmacol 42: 66–75

    Article  Google Scholar 

  • Solyom L, Heseltine GFD, McClure DJ et al (1973) Behavior therapy versus drug therapy in the treatment of phobic neurosis. Can J Psychiatry 18: 25–32

    Google Scholar 

  • Teich MJ (1983) A comparison of behavioral and pharmacological approaches to the treatment of agoraphobia. Doctoral dissertation, Stanford University, University Microfilms International

    Google Scholar 

  • The Quality Assurance Project (1985) Treatment outlines for the management of anxiety states. Aust NZ J Psychiatry 19: 138–151

    Google Scholar 

  • Tyrer P, Candy J, Kelly D (1973) A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacologia 32: 237–254

    Article  PubMed  Google Scholar 

  • Weissman MM, Prusoff BA, Klerman GL (1978) Personality as a predictor of long-term outcome of depression Am J Psychiatry 137: 797–800

    Google Scholar 

  • Williams SL, Rappoport A (1983) Cognitive treatment in the natural environment for agoraphobics. Behav Res Ther 14: 299–313

    Article  Google Scholar 

  • Zitrin CM, Klein DF, Woerner MG et al (1983) Treatment of phobias I: comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40: 125–138

    PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Andrews, G., Moran, C. (1988). Exposure Treatment of Agoraphobia with Panic Attacks: Are Drugs Essential?. In: Hand, I., Wittchen, HU. (eds) Panic and Phobias 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73543-1_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73543-1_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73545-5

  • Online ISBN: 978-3-642-73543-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics